Harry "Skip" Brandon Speaks on Panel at FCPA Seminar

(202) 887-9363

In the News


Harry “Skip” Brandon Speaks on Panel at FCPA Seminar

May 15, 2014

US Department of State
Washington, DC



Harry “Skip” Brandon of Smith Brandon International, Inc. joined a panel of experts for a panel discussion entitled, “Due Diligence: Third Party Vetting, Mergers and Acquisitions.” The panel was part of an all-day seminar organized by the US Department of State’s Overseas Security Advisory Council (OSAC) focused on the Foreign Corrupt Practices Act (FCPA).

This one-day seminar provided FCPA guidance from many different perspectives, including the Department of Justice, due diligence and compliance best practices from the corporate, NGO, and academic perspectives, FCPA insight from the Departments of Commerce and State, FCPA analysis by region, and other pertinent topics.

The panel also discussed how to conduct effective due diligence on the parties involved in mergers & acquisitions with companies abroad. The panel was moderated by Jessica Tillipman, Assistant Dean for Field Placement at George Washington University. Harry “Skip” Brandon, Chief Operating Officer of Smith Brandon International, Inc. was one of the panel members along with Alice Fischer, Managing Partner at Lantham & Watkins LLP and Anne Elikins Murray, Of Counsel at Orrick, Herrington & Sutcliffe LLP.

What Others Are Saying

“Excellent report as always. We truly found it extremely helpful.”

DirectorEuropean Hotel Group

“As always, perfect. The client on the project in Taiwan was most pleased.”

DirectorInvestigative Firm

“...you definitely helped [our division] and the whole company improve ... so [we] can make better informed decisions regarding our strategy.”

Strategy DirectorMajor Infrastructure Firm

“The reporting you just furnished us has helped us avoid a major mistake in looking at the potential new partner ... we are very pleased.”

VP for ComplianceInternational Construction Company

“Many thanks for your reporting and willingness to talk with us about what it means. You are correct, we do have an issue and we will take corrective action immediately.”

Corporate CounselInternational Pharmaceutical Company
Prev Next